AU2001265296A1 - Compositions and methods for the therapy and diagnosis of ovarian cancer - Google Patents
Compositions and methods for the therapy and diagnosis of ovarian cancerInfo
- Publication number
- AU2001265296A1 AU2001265296A1 AU2001265296A AU6529601A AU2001265296A1 AU 2001265296 A1 AU2001265296 A1 AU 2001265296A1 AU 2001265296 A AU2001265296 A AU 2001265296A AU 6529601 A AU6529601 A AU 6529601A AU 2001265296 A1 AU2001265296 A1 AU 2001265296A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- therapy
- compositions
- methods
- ovarian cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pregnancy & Childbirth (AREA)
- Animal Behavior & Ethology (AREA)
- Gynecology & Obstetrics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20748400P | 2000-05-26 | 2000-05-26 | |
US60/207,484 | 2000-05-26 | ||
PCT/US2001/017756 WO2001092581A2 (en) | 2000-05-26 | 2001-05-29 | Compositions and methods for the therapy and diagnosis of ovarian cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001265296A1 true AU2001265296A1 (en) | 2001-12-11 |
Family
ID=22770753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001265296A Abandoned AU2001265296A1 (en) | 2000-05-26 | 2001-05-29 | Compositions and methods for the therapy and diagnosis of ovarian cancer |
Country Status (6)
Country | Link |
---|---|
US (1) | US20020132237A1 (ja) |
EP (1) | EP1356092A2 (ja) |
JP (1) | JP2004511212A (ja) |
AU (1) | AU2001265296A1 (ja) |
CA (1) | CA2411404A1 (ja) |
WO (1) | WO2001092581A2 (ja) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030232056A1 (en) | 1999-09-10 | 2003-12-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6461843B1 (en) * | 2001-02-16 | 2002-10-08 | Applera Corporation | Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof |
EP1383922A4 (en) | 2001-04-10 | 2005-03-30 | Agensys Inc | NUCLEIC ACID AND ASSOCIATED PROTEIN SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER WITH THE LABEL 158P3D2 |
AU2002318112B2 (en) | 2001-04-10 | 2007-12-06 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
US20030120040A1 (en) | 2001-06-29 | 2003-06-26 | Genentech, Inc. | Secreted and Transmembrane polypeptides and nucleic acids encoding the same |
ITMI20012082A1 (it) * | 2001-10-09 | 2003-04-09 | Danieli & Co Ohg S P A | Dispositivo di bloccaggio e sbloccaggio per cuscinetti di rulli di laminazione |
US20040126762A1 (en) * | 2002-12-17 | 2004-07-01 | Morris David W. | Novel compositions and methods in cancer |
US20040166490A1 (en) * | 2002-12-17 | 2004-08-26 | Morris David W. | Novel therapeutic targets in cancer |
US20060040262A1 (en) * | 2002-12-27 | 2006-02-23 | Morris David W | Novel compositions and methods in cancer |
US20040180344A1 (en) * | 2003-03-14 | 2004-09-16 | Morris David W. | Novel therapeutic targets in cancer |
WO2003059256A2 (en) * | 2001-12-21 | 2003-07-24 | Idec Pharmaceuticals Corporation | Genes overexpresses by ovarian cancer and their use in developing novel therapeutics especially antibodies |
JPWO2003070936A1 (ja) * | 2002-02-20 | 2005-06-09 | 山之内製薬株式会社 | 新規ポリペプチド |
US20040023267A1 (en) * | 2002-03-21 | 2004-02-05 | Morris David W. | Novel compositions and methods in cancer |
US9200036B2 (en) | 2002-07-12 | 2015-12-01 | The Johns Hopkins University | Mesothelin vaccines and model systems |
US20090110702A1 (en) | 2002-07-12 | 2009-04-30 | The Johns Hopkins University | Mesothelin Vaccines and Model Systems and Control of Tumors |
US20050175625A1 (en) | 2002-07-12 | 2005-08-11 | The Johns Hopkins University | Mesothelin vaccines and model systems |
JP4186004B2 (ja) | 2002-08-14 | 2008-11-26 | 独立行政法人産業技術総合研究所 | 新規n−アセチルガラクトサミン転移酵素およびそれをコードする核酸 |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
AU2002951346A0 (en) * | 2002-09-05 | 2002-09-26 | Garvan Institute Of Medical Research | Diagnosis of ovarian cancer |
US7718787B2 (en) * | 2002-10-18 | 2010-05-18 | Lg Life Sciences Limited | Gene families associated with cancers |
WO2004065576A2 (en) | 2003-01-15 | 2004-08-05 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the treatment of urological disorder using differential expressed polypeptides |
JP2009520459A (ja) * | 2003-02-14 | 2009-05-28 | サイグレス ディスカバリー, インコーポレイテッド | 癌における治療標的 |
US20040219528A1 (en) * | 2003-04-15 | 2004-11-04 | Morris David W. | Novel therapeutic targets in cancer |
US20040170982A1 (en) * | 2003-02-14 | 2004-09-02 | Morris David W. | Novel therapeutic targets in cancer |
WO2004091548A2 (en) * | 2003-04-15 | 2004-10-28 | Avalon Pharmaceuticals, Inc | Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
GB0320648D0 (en) * | 2003-09-03 | 2003-10-01 | Randox Lab Ltd | Molecular marker |
US20070178458A1 (en) * | 2003-09-05 | 2007-08-02 | O'brien Philippa | Methods of diagnosis and prognosis of ovarian cancer II |
CA2559211A1 (en) | 2004-03-19 | 2005-09-29 | Yale University | Detection, isolation and uses of renalase (monoamine oxidase c) |
JP4604158B2 (ja) * | 2004-03-26 | 2010-12-22 | 生化学工業株式会社 | 活性硫酸運搬作用を有するタンパク質および組織の癌化の検出方法 |
US8940488B2 (en) | 2004-03-31 | 2015-01-27 | Hiroyuki Aburatani | Cancer diagnosis and treatment of cancer using anti-robo 1 antibody |
JP4913590B2 (ja) | 2004-03-31 | 2012-04-11 | 株式会社ペルセウスプロテオミクス | 抗robo1抗体を用いる癌の診断および治療 |
WO2006090389A2 (en) | 2005-02-24 | 2006-08-31 | Compugen Ltd. | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof |
JP2009516693A (ja) | 2005-11-21 | 2009-04-23 | イエール ユニバーシティ | レナラーゼ(モノアミンオキシダーゼc)の調節方法 |
AR059900A1 (es) | 2006-03-17 | 2008-05-07 | Genentech Inc | Anticuerpos anti-tat226 e inmunoconjugados |
EP2419534A4 (en) * | 2009-04-14 | 2012-08-22 | Socpra Sciences Sante Et Humaines S E C | SIGNATURE OVARIAN CARCINOMA-SPECIFIC SEPARATE PROTEIN FORMS |
CN103209987B (zh) | 2010-09-22 | 2017-06-06 | 艾丽奥斯生物制药有限公司 | 取代的核苷酸类似物 |
US20130303400A1 (en) * | 2010-11-26 | 2013-11-14 | Robert Zeillinger | Multimarker panel |
KR20140014116A (ko) | 2010-12-20 | 2014-02-05 | 제넨테크, 인크. | 항-메소텔린 항체 및 면역접합체 |
AU2012358804B2 (en) | 2011-12-22 | 2018-04-19 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
WO2013142124A1 (en) | 2012-03-21 | 2013-09-26 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
EP2827876A4 (en) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG |
WO2018195273A1 (en) * | 2017-04-19 | 2018-10-25 | The Corporation Of Mercer University | Sam-1 protein, composition and methods of use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0646129A4 (en) * | 1992-05-11 | 1995-07-19 | Ludwig Inst Cancer Res | MOLECULES, WHICH ARE SIMILAR TO THE TYROSIN KINASE OF THE RECEPTOR TYPE (01/13/94). |
JP3681405B2 (ja) * | 1997-02-21 | 2005-08-10 | タカラバイオ株式会社 | 癌関連遺伝子 |
DE19817557A1 (de) * | 1998-04-09 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe |
-
2001
- 2001-05-29 CA CA002411404A patent/CA2411404A1/en not_active Abandoned
- 2001-05-29 AU AU2001265296A patent/AU2001265296A1/en not_active Abandoned
- 2001-05-29 JP JP2002500772A patent/JP2004511212A/ja not_active Withdrawn
- 2001-05-29 EP EP01939819A patent/EP1356092A2/en not_active Withdrawn
- 2001-05-29 US US09/867,701 patent/US20020132237A1/en not_active Abandoned
- 2001-05-29 WO PCT/US2001/017756 patent/WO2001092581A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001092581A2 (en) | 2001-12-06 |
WO2001092581A3 (en) | 2003-08-21 |
EP1356092A2 (en) | 2003-10-29 |
JP2004511212A (ja) | 2004-04-15 |
CA2411404A1 (en) | 2001-12-06 |
WO2001092581A8 (en) | 2002-04-11 |
US20020132237A1 (en) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002251841A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002251844A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU3983201A (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
AU3491001A (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002311909A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002254482A1 (en) | Compositions and methods for the therapy and diagnosis of kidney cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002359330A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU3483001A (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2001273149A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer |